Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02323763 · ClinicalTrials.gov registry record
An fMRI Study on Temporal Discounting in Bipolar Disorder
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 28
- Enrollment target
NCT02323763: Completed study, sponsored by Massachusetts General Hospital.
NCT02323763 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02323763 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The investigators propose to explore the link between bipolar disorder, anxiety, and suicide by investigating intertemporal discounting in depressed, suicidal patients with bipolar I and II disorder who have various levels of anxiety. The investigators will determine the effect of anxiety on their intertemporal discounting (small rewards now compared to larger rewards later) in a decision-making paradigm and investigate the associated functional neuroanatomy using functional magnetic resonance imaging (fMRI).
Interventions
- OTHER fMRI Scanning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2014-07-14 |
| Est. Completion | 2016-08-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02323763
The ClinicalTrials.gov registry entry for NCT02323763 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fMRI Scanning is the first listed.
NCT02323763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02323763 about?
NCT02323763 is a clinical study titled "An fMRI Study on Temporal Discounting in Bipolar Disorder". The investigators propose to explore the link between bipolar disorder, anxiety, and suicide by investigating intertemporal discounting in depressed, suicidal patients with bipolar I and II disorder who have various levels of anxiety. The investigators will determine the effect of anxiety on their i...
What is the current status of trial NCT02323763?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2014-07-14. Estimated completion is 2016-08-29.
What interventions are being tested in trial NCT02323763?
The interventions under investigation include: fMRI Scanning (OTHER).
Who is sponsoring clinical trial NCT02323763?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.